Skip to main content
Top
Published in:

Open Access 01-12-2024 | Research

Regulation of mark-up on medicine prices in Zimbabwe: a pilot survey from 92 community pharmacies in the metropolitan area of Harare

Authors: Hilma N Nakambale, Penelope Tambama, Varsha Bangalee

Published in: Health Economics Review | Issue 1/2024

Login to get access

Abstract

Background

Medicine pricing in the community pharmacy sector in Zimbabwe significantly influences accessibility to health care. In this pilot survey, we investigated how community pharmacies in Zimbabwe apply various mark-up strategies to essential and non-essential medicines, and gathered community pharmacists’ perspectives on mark-up regulation.

Methods

Using an adapted methodology endorsed by the World Health Organization and Health Action International for studying medicine prices and availability, we conducted a quantitative cross-sectional pilot survey for 46 medicines (31 essential and 15 non-essential) identified using the Zimbabwe Essential Medicines List and classified according to the Vital, Essential, and Non-essential (VEN) tool. We conducted the pilot survey in 92 community pharmacies in the metropolitan area of Harare, Zimbabwe.

Results

We gathered a total of 92 responses from 167 distributed questionnaires. The most prevalent mark-up strategy was the cost-plus fixed percentage.The median mark-up for all medicines in the community pharmacies was 60% (interquartile range 50- 82%). We found a statistically significant difference in the median mark-up by essentiality of medicines (p < 0.001), essential medicines had a median mark-up price of 62% while non-essential medicines had a mark-up of 56%. Antipsychotics had the highest mark-up at 82%, while anti-neoplastic medicine had the lowest at 36%. Overall, 55% of the community pharmacists did not support mark-up regulation.

Conclusion

Mark-up strategies varied across community pharmacies in the metropolitan area of Harare. Without mark-up regulation, essential medicines remain significantly expensive in Zimbabwe. We recommend mark-up regulation in Zimbabwe’s community pharmacy sector and emphasize the effective use of multiple pricing strategies to reduce medicine prices.       .
Literature
1.
go back to reference Morgan SG, Bathula HS, Moon S. Pricing of pharmaceuticals is becoming a major challenge for health systems. BMJ. 2020;368:l4627.CrossRefPubMed Morgan SG, Bathula HS, Moon S. Pricing of pharmaceuticals is becoming a major challenge for health systems. BMJ. 2020;368:l4627.CrossRefPubMed
3.
go back to reference Ondo Z. Regulatory Analysis of Mark-up structure in Medicine prices by the Pharmaceutical Industry in South Africa. J Pharm Care Health Syst. 2019;6(2). Ondo Z. Regulatory Analysis of Mark-up structure in Medicine prices by the Pharmaceutical Industry in South Africa. J Pharm Care Health Syst. 2019;6(2).
4.
go back to reference Mutyavaviri SN, Mensah KB, Marume A, Boamah Mensah AB, Bangalee V. Price, availability, and affordability of Antineoplastic Medicines in Harare’s public and private institutions: implication for Access. Value Health Reg Issues. 2021;25:118–25.CrossRefPubMed Mutyavaviri SN, Mensah KB, Marume A, Boamah Mensah AB, Bangalee V. Price, availability, and affordability of Antineoplastic Medicines in Harare’s public and private institutions: implication for Access. Value Health Reg Issues. 2021;25:118–25.CrossRefPubMed
5.
go back to reference Marume A, Nyandoro G, Mutingwende I, Murambinda P, Bangalee V. Price and availability survey of essential medicines in the Harare province, Zimbabwe. Cent Afr J Med. 2018;63:7–8. Marume A, Nyandoro G, Mutingwende I, Murambinda P, Bangalee V. Price and availability survey of essential medicines in the Harare province, Zimbabwe. Cent Afr J Med. 2018;63:7–8.
7.
go back to reference Hwang TJ, Kesselheim AS, Vokinger KN. Reforming the World Health Organization’s essential Medicines list: essential but unaffordable. JAMA. 2022;328(18):1807–8.CrossRefPubMed Hwang TJ, Kesselheim AS, Vokinger KN. Reforming the World Health Organization’s essential Medicines list: essential but unaffordable. JAMA. 2022;328(18):1807–8.CrossRefPubMed
8.
go back to reference Piggott T, Nowak A, Brignardello-Petersen R, Cooke GS, Huttner B, Schunemann HJ, et al. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO. BMJ Open. 2022;12(2):e053349.CrossRefPubMedPubMedCentral Piggott T, Nowak A, Brignardello-Petersen R, Cooke GS, Huttner B, Schunemann HJ, et al. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO. BMJ Open. 2022;12(2):e053349.CrossRefPubMedPubMedCentral
9.
go back to reference The Zimbabwe National Medicines Policy Z. National Medicines Policy. 2011. In: Services DoP, editor. Harare2011. The Zimbabwe National Medicines Policy Z. National Medicines Policy. 2011. In: Services DoP, editor. Harare2011.
10.
go back to reference Musiza PT. Pricing strategies of Pharmaceutical wholesalers in Zimbabwe and their impact on Service Provision. OALib. 2023;10(05):1–30.CrossRef Musiza PT. Pricing strategies of Pharmaceutical wholesalers in Zimbabwe and their impact on Service Provision. OALib. 2023;10(05):1–30.CrossRef
11.
go back to reference Paidamoyo C. Pharmacies Warned Over Escalating Drug Prices. The Herald. 2019 August 31, 2019. Paidamoyo C. Pharmacies Warned Over Escalating Drug Prices. The Herald. 2019 August 31, 2019.
12.
go back to reference Mzila P. Pharmacies and the 3-tier Pricing System. The Herald. 2018 December 4, 2018. Mzila P. Pharmacies and the 3-tier Pricing System. The Herald. 2018 December 4, 2018.
13.
go back to reference Paidamoyo C. Pharmacies Continue Milking Patients. The Herald. 2019 August 30, 2019. Paidamoyo C. Pharmacies Continue Milking Patients. The Herald. 2019 August 30, 2019.
14.
go back to reference WHO/HAI. Measuring medicine prices, availability, affordability and price components. Switzerland; 2008. WHO/HAI. Measuring medicine prices, availability, affordability and price components. Switzerland; 2008.
15.
go back to reference Lane J, Nakambale H, Kadakia A, Dambisya Y, Stergachis A, Odoch WD. A systematic scoping review of medicine availability and affordability in Africa. BMC Health Serv Res. 2024;24(1):91.CrossRefPubMedPubMedCentral Lane J, Nakambale H, Kadakia A, Dambisya Y, Stergachis A, Odoch WD. A systematic scoping review of medicine availability and affordability in Africa. BMC Health Serv Res. 2024;24(1):91.CrossRefPubMedPubMedCentral
16.
go back to reference Deressa MB, Beressa TB, Jemal A. Analysis of Pharmaceuticals Inventory Management Using ABC-VEN Matrix Analysis in Selected Health Facilities of West Shewa Zone, Oromia Regional State, Ethiopia. Integr Pharm Res Pract. 2022;11:47–59.PubMedPubMedCentral Deressa MB, Beressa TB, Jemal A. Analysis of Pharmaceuticals Inventory Management Using ABC-VEN Matrix Analysis in Selected Health Facilities of West Shewa Zone, Oromia Regional State, Ethiopia. Integr Pharm Res Pract. 2022;11:47–59.PubMedPubMedCentral
17.
go back to reference Mohammed SA, Workneh BD. Critical Analysis of Pharmaceuticals Inventory Management using the ABC-VEN Matrix in Dessie Referral Hospital, Ethiopia. Integr Pharm Res Pract. 2020;9:113–25.PubMedPubMedCentral Mohammed SA, Workneh BD. Critical Analysis of Pharmaceuticals Inventory Management using the ABC-VEN Matrix in Dessie Referral Hospital, Ethiopia. Integr Pharm Res Pract. 2020;9:113–25.PubMedPubMedCentral
18.
go back to reference Kamvura TT, Dambi JM, Chiriseri E, Turner J, Verhey R, Chibanda D. Barriers to the provision of non-communicable disease care in Zimbabwe: a qualitative study of primary health care nurses. BMC Nurs. 2022;21(1):64.CrossRefPubMedPubMedCentral Kamvura TT, Dambi JM, Chiriseri E, Turner J, Verhey R, Chibanda D. Barriers to the provision of non-communicable disease care in Zimbabwe: a qualitative study of primary health care nurses. BMC Nurs. 2022;21(1):64.CrossRefPubMedPubMedCentral
19.
go back to reference Smit M, Olney J, Ford NP, Vitoria M, Gregson S, Vassall A, Hallett TB. The growing burden of noncommunicable disease among persons living with HIV in Zimbabwe. AIDS. 2018;32(6):773–82.CrossRefPubMed Smit M, Olney J, Ford NP, Vitoria M, Gregson S, Vassall A, Hallett TB. The growing burden of noncommunicable disease among persons living with HIV in Zimbabwe. AIDS. 2018;32(6):773–82.CrossRefPubMed
20.
go back to reference Salah I, Kheder HMA. Evaluating Medicines prices, availability, affordability and price components in Sudan. Sudan Med Monit. 2014;9(1):19–30.CrossRef Salah I, Kheder HMA. Evaluating Medicines prices, availability, affordability and price components in Sudan. Sudan Med Monit. 2014;9(1):19–30.CrossRef
21.
go back to reference Lee KS, Kassab YW, Taha NA, Zainal ZA. A systematic review of pharmaceutical price mark-up practice and its implementation. Explor Res Clin Soc Pharm. 2021;2:100020.PubMedPubMedCentral Lee KS, Kassab YW, Taha NA, Zainal ZA. A systematic review of pharmaceutical price mark-up practice and its implementation. Explor Res Clin Soc Pharm. 2021;2:100020.PubMedPubMedCentral
22.
go back to reference Lee KS, Kassab YW, Taha NA, Zainal ZA. Factors impacting Pharmaceutical prices and affordability. Narrative Rev Pharm (Basel). 2020;9(1). Lee KS, Kassab YW, Taha NA, Zainal ZA. Factors impacting Pharmaceutical prices and affordability. Narrative Rev Pharm (Basel). 2020;9(1).
23.
go back to reference WHO. WHO guideline on country pharmaceutical pricing policies. 2020. WHO. WHO guideline on country pharmaceutical pricing policies. 2020.
24.
go back to reference Reporters H. Drug Prices Skyrocket. The Herald. 2018 October 17, 2018. Reporters H. Drug Prices Skyrocket. The Herald. 2018 October 17, 2018.
25.
go back to reference Sisay M, Amare F, Hagos B, Edessa D. Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology. J Pharm Policy Pract. 2021;14(1):57.CrossRefPubMedPubMedCentral Sisay M, Amare F, Hagos B, Edessa D. Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology. J Pharm Policy Pract. 2021;14(1):57.CrossRefPubMedPubMedCentral
27.
go back to reference Liu Z, Zou K, Liu D, Zhang M, Shi Y, Chen Z, et al. The price and affordability of essential medicines, progress and regional distribution in China: a systematic review. Front Pharmacol. 2023;14:1153972.CrossRefPubMedPubMedCentral Liu Z, Zou K, Liu D, Zhang M, Shi Y, Chen Z, et al. The price and affordability of essential medicines, progress and regional distribution in China: a systematic review. Front Pharmacol. 2023;14:1153972.CrossRefPubMedPubMedCentral
Metadata
Title
Regulation of mark-up on medicine prices in Zimbabwe: a pilot survey from 92 community pharmacies in the metropolitan area of Harare
Authors
Hilma N Nakambale
Penelope Tambama
Varsha Bangalee
Publication date
01-12-2024
Publisher
Springer Berlin Heidelberg
Published in
Health Economics Review / Issue 1/2024
Electronic ISSN: 2191-1991
DOI
https://doi.org/10.1186/s13561-024-00574-8